These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4385938)

  • 21. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. II. Accumulation of 5-hydroxytryptamine in nerve vesicles containing norepinephrine in rat vas deferens.
    Zieher LM; Jaim-Etcheverry G
    J Pharmacol Exp Ther; 1971 Jul; 178(1):30-41. PubMed ID: 5087403
    [No Abstract]   [Full Text] [Related]  

  • 22. 6-Fluorocatecholamines as false adrenergic neurotransmitters.
    Chiueh CC; Zukowska-Grojec Z; Kirk KL; Kopin IJ
    J Pharmacol Exp Ther; 1983 Jun; 225(3):529-33. PubMed ID: 6134813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenergic nerve particles in relation to uptake and release of neurotransmitter. The Sir Henry Dale Lecture for 1972.
    von Euler US
    J Endocrinol; 1972 Nov; 55(2):ii-ix. PubMed ID: 4344239
    [No Abstract]   [Full Text] [Related]  

  • 24. Proceedings: Effect of nicotine and nicotine monomethiodide on vascular adrenergic neuroeffector transmission.
    Nedergaard OA
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R69. PubMed ID: 4367356
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemical sympathectomy of the cat with 6-hydroxydopamine.
    Haeusler G; Haefely W; Thoenen H
    J Pharmacol Exp Ther; 1969 Nov; 170(1):50-61. PubMed ID: 5351006
    [No Abstract]   [Full Text] [Related]  

  • 26. Regulation of norepinephrine biosynthesis.
    Weiner N
    Annu Rev Pharmacol; 1970; 10():273-90. PubMed ID: 4315686
    [No Abstract]   [Full Text] [Related]  

  • 27. Unidirectional fluxes in isolated splenic nerve vesicles measured by a millipore filter technique: effects of noradrenaline and competitive reversal of reserpine inhibition.
    Klein RL; Lagercrantz H
    Acta Physiol Scand; 1971 Oct; 83(2):179-90. PubMed ID: 4398861
    [No Abstract]   [Full Text] [Related]  

  • 28. Correlation of norepinephrine content with observations of adrenergic nerves after a single dose of 6-hydroxydopamine in the rat.
    Goldman H; Jacobowitz D
    J Pharmacol Exp Ther; 1971 Jan; 176(1):119-33. PubMed ID: 5569629
    [No Abstract]   [Full Text] [Related]  

  • 29. Degenerative and nondegenerative effects of 6-hydroxydopamine on adrenergic nerves.
    Jonsson G; Sachs C
    J Pharmacol Exp Ther; 1972 Mar; 180(3):625-35. PubMed ID: 4335111
    [No Abstract]   [Full Text] [Related]  

  • 30. Ultrastructural aspects of neurotransmitter storage in adrenergic nerves.
    Jaim-Etcheverry G; Zieher LM
    Adv Cytopharmacol; 1971 May; 1():343-61. PubMed ID: 4127777
    [No Abstract]   [Full Text] [Related]  

  • 31. Adrenergic neurotransmitter storage and release.
    Von Euler US
    Hawaii Med J; 1974 Oct; 33(10):371-5. PubMed ID: 4376551
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence that action potential-induced Ca2+ influx is necessary but not sufficient to release transmitter from sympathetic nerve terminals.
    Msghina M; Stjärne E; Astrand P; Stjärne L
    Acta Physiol Scand; 1990 Feb; 138(2):239-40. PubMed ID: 1969221
    [No Abstract]   [Full Text] [Related]  

  • 33. Isolation and characterization of sympathetic nerve trunk vesicles.
    Lagercrantz H
    Acta Physiol Scand Suppl; 1971; 366():1-44. PubMed ID: 4328857
    [No Abstract]   [Full Text] [Related]  

  • 34. Differentiation of norepinephrine storage compartments in peripheral adrenergic nerves.
    Van Orden LS; Schaefer JM; Burke JP; Lodoen FV
    J Pharmacol Exp Ther; 1970 Sep; 174(3):357-68. PubMed ID: 5456169
    [No Abstract]   [Full Text] [Related]  

  • 35. [Adrenergic mechanisms of antidepressant action].
    Mashkovskiĭ MD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):750-9. PubMed ID: 4916171
    [No Abstract]   [Full Text] [Related]  

  • 36. [Presynaptic receptors and modulation of neurotransmitter release].
    Langer SZ
    J Pharmacol; 1982; 13 Suppl 1():45-52. PubMed ID: 6125629
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of drugs modifying sympathetic nervous system activity in the treatment of hypertension.
    Peart S
    J Hypertens Suppl; 1985 Dec; 3(4):S51-5. PubMed ID: 3007706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of ouabain-induced noradrenaline and acetylcholine release from in situ cardiac autonomic nerve endings.
    Yamazaki T; Akiyama T; Kitagawa H; Komaki F; Mori H; Kawada T; Sunagawa K; Sugimachi M
    Acta Physiol (Oxf); 2007 Dec; 191(4):275-84. PubMed ID: 17995575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase in the vesicular noradrenaline of nerve terminals.
    Fillenz M; Howe PR
    J Physiol; 1971; 217 Suppl():27P-28P. PubMed ID: 5571930
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanism of nicotine-induced release of norepinephrine from adrenergic nerve endings: does it act like tyramine?
    Jayasundar S; Vohra MM
    Indian J Exp Biol; 1977 Dec; 15(12):1218-9. PubMed ID: 614227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.